"QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
Clinical trial NCT04373642 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04373642
- Sponsor
- University of Oklahoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-23
- Primary completion
- 2025-10-14
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.